mayne 614 mayne 614 (Methylphenidate Hydrochloride Extended-Release (LA) 60 mg)
Pill with imprint mayne 614 mayne 614 is Yellow, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release (LA) 60 mg. It is supplied by Mayne Pharma US.
Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 60 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for mayne 614 mayne 614
Methylphenidate Hydrochloride Extended-Release (LA)
- Imprint
- mayne 614 mayne 614
- Strength
- 60 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cns stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Mayne Pharma US
- Manufacturer
- Catalent Pharma Solutions
- National Drug Code (NDC)
- 51862-0614
More about methylphenidate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 878 Reviews
- Drug class: CNS stimulants
- FDA Alerts (3)
Consumer resources
- Patient Information
- Methylphenidate transdermal
- Methylphenidate Oral, Transdermal (Advanced Reading)
- Methylphenidate Transdermal (Advanced Reading)
- Methylphenidate Chewable Tablets
- ... +9 more
- Other brands
- Ritalin, Concerta, Ritalin LA, Adhansia XR, ... +11 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.